Stem Cell Research Act 2026 (S. 4109)

Summary

Provides new funding for national stem cell and cord blood programs to help find treatments for diseases.

What problem does this solve?

Funding for national stem cell and cord blood programs is about to run out, which could stop important medical research. This bill gives more money to these programs so they can keep working to find cures for diseases until 2031.

What does this bill do?

Funds the C.W. Bill Young Cell Transplantation Program

Provides $33,009,000 each year from fiscal year 2027 through 2031 for the national program that helps with cell transplantation.

Extends the national cord blood inventory program

Continues the national cord blood inventory program, which collects and stores cord blood for treatments, through the year 2031.

Who does this affect?

Patients needing cell transplants
Medical researchers
Healthcare providers

What is the real world impact?

•

Ensures continuity of medical research

Continues funding for established stem cell and cord blood programs that help treat diseases. This prevents a lapse in funding that could disrupt ongoing research and patient access to therapies.

When does this start?

This bill outlines new funding and program extensions that will take effect from fiscal year 2027 through 2031.

Cell Transplantation Program Funding

Provides $33,009,000 for each fiscal year from 2027 through 2031.

Cord Blood Inventory Extension

The authorization for the cord blood inventory program is extended to 2031.